CNO (CNO) Up 6.1% Since Last Earnings Report: Can It Continue?

CNO Financial (CNO) reported Q2 adjusted EPS of $0.87, beating estimates by 2.4% despite a 17% year-over-year decline, while operating revenues rose 8% to $1.2 billion, significantly exceeding consensus. This performance was driven by strong annuity collected premiums and rising new annualized premiums, though partially offset by increased expenses and net investment losses. Shares have since climbed 6.1%, outperforming the S&P 500, as the company reiterated its 2025 operating EPS and excess cash flow guidance, and narrowed its expense ratio projection.

Analysis

CNO Financial (CNO) presents a mixed financial profile following its second-quarter earnings, where shares have outperformed the S&P 500 with a 6.1% gain. The company's operating revenues grew a robust 8% year-over-year to $1.2 billion, decisively beating consensus estimates by 19.3%, fueled by strong annuity collected premiums (+19% YoY) and double-digit growth in new annualized premiums for life and health products. However, this top-line strength was negated by a 12.9% escalation in total benefits and expenses, leading to a 17% year-over-year decline in adjusted EPS to $0.87. The balance sheet reflects a similar duality: the debt-to-capital ratio improved significantly by 760 basis points, but unrestricted cash and cash equivalents plunged 53.8% from the 2024 year-end level. Despite this cash reduction, CNO returned $116.7 million to shareholders via buybacks and dividends and maintains a substantial $540.4 million repurchase authorization. Management's reaffirmed 2025 EPS guidance and narrowed expense ratio forecast suggest operational confidence, aligning with the stock's 'A' grade for value, which contrasts sharply with its 'F' for growth and overall 'Hold' rating from Zacks.

Key Decisions for Investors

• Value-oriented investors may find CNO attractive due to its strong capital return program, improving operating return on equity, and a stated goal of further deleveraging its balance sheet.
• Investors should closely monitor the company's ability to control operating expenses, as the 12.9% YoY increase was a primary driver of the 17% decline in adjusted EPS despite strong revenue growth.
• Given the stock's recent 6.1% outperformance against a backdrop of flat analyst estimate revisions and a significant 53.8% drop in unrestricted cash, a neutral stance may be prudent until profitability trends improve.